Drawing for METEOR BIOTECH

USPTO serial 79411347

METEOR BIOTECH

Reviewed by CopyMark Law Group

Reg. 8090562Status 700Registered
Filing date
Status date
Registration date
Jan 6, 2026
Examiner
MILMOE, MAUREEN H
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with METEOR BIOTECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Minchul Yang

Minchul Yang STIP Law Group, LLC40 W. Chesapeake Ave, Suite 506Towson, MD 21204United States

Goods and services

ClassDescriptionStatusFirst use
005Reagents for medical use; Drugs for medical purposes, namely, acetaminophen; Enzymes for medical purposes; Enzyme preparations for medical purposes; Nucleic acid sequences for medical and veterinary purposes; Diagnostic chemical preparations for medical purposes for use in DNA analysis; In vitro diagnostic preparations for medical purposes; Diagnostic test reagents for medical or veterinary purposes; Chemical reagents for medical or veterinary purposes; Reagents for use in medical genetic testingACTIVE—
009Diagnostic apparatus for research laboratory use for DNA analysis; Laboratory devices for DNA sequencing, not for medical purposes; Laboratory devices for analyzing polynucleic acid, not for medical purposes; Reagent containers being chips having multi-well arrays for use with protein analysis apparatus used in chemical analysis and biological analysis for laboratory research use; Laboratory devices for analyzing and extracting genes, not for medical purposes; DNA chips; Laboratory apparatus and instruments for preparing nucleic acid samples; Laboratory apparatus, namely, devices for analyzing protein sequences, not for medical purposes; Plates having multi-well arrays for analyzing genes for laboratory research useACTIVE—
042Biomarker discovery services being medical research; Custom design and development of equipment for manufacturing pharmaceuticals; Biological laboratory services relating to the selection and screening of biomarkers in biological tissue samples for scientific research purposes; Design and development of equipment for selection and screening of biomarkers in in biological tissue samples; Scientific research for medical purposes in the area of cancerous diseases; Consulting services in the field of biological sequence processing and analysis for medical research purposes; Research in the field of gene expression analysis; Development of computer software for use with medical equipment; Providing computer software technical support services, namely, troubleshooting of computer software problems in the field of medical diagnostics; Product development in the field of medical diagnostic devices; Blood testing services for medical research purposesACTIVE—
044Medical analysis for the diagnosis and treatment of persons; Medical laboratory analysis services relating to the treatment of persons; Medical services relating to the removal, treatment and processing of human blood; RNA or DNA analysis being medical analysis services for the diagnosis of cancer; Medical analysis services for the diagnosis of cancer; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Provision of genetic testing for medical purposes; Provision of information for medical purposes in the field of gene therapy for cancer treatment; Medical diagnostic services; medical screening; Genetic counseling for medical purposes; Medical analysis services of biomarkers for diagnostic purposes provided by medical laboratoriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 15, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 15, 2026FIMPFINAL DISPOSITION PROCESSED—
May 21, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 4, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 4, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 6, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 6, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 6, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 18, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 18, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 12, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 16, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 15, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 15, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 15, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 29, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 29, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 29, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 5, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 5, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Jul 5, 2025CNSLSUSPENSION LETTER WRITTEN—
Jul 1, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 1, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 1, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 17, 2025RFNTREFUSAL PROCESSED BY IB—
Jan 2, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 2, 2025RFRRREFUSAL PROCESSED BY MPU—
Dec 14, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 13, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2024DOCKASSIGNED TO EXAMINER—
Dec 6, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 6, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 5, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance